ABCB1 and neoplasm: The growth rate of the MDR1-expressing L5178 tumours was significantly reduced by administration of TBN (10 mg kg–1) 3 h before doxorubicin (4 mg kg–1) as compared with doxorubicin alone (Figure 5A).